Neuron23
Neuron23™ Inc. is an early stage biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases.
Org chart
Nancy Stagliano
CEO & Board Chair
Collapse
Adam Knight
Founder and CBO
Desmond Padhi
Interim Head of Translational Medicine
Steve Wood
VP Drug Discovery
Zhonghua Pei
VP Chemistry
Arash Rassoulpour
VP Research Operations
Luc Desnoyers
VP Translational R&D
Natalie Leonard
Associate Director, Project Management
Teams
View all
Discover similar companies
Xilio Therapeutics
Series C • Waltham, United States
Apollomics
Series C • Foster City, United States
Enko
Series C • Stonington, United States
Checkmate Pharmaceuticals
Series C • Cambridge, United States
Cullinan
Series C • Cambridge, United States
Adagio Therapeutics
Series C • Waltham, United States
Vizgen
Series C • Cambridge, United States
Encodia
Series C • San Diego, United States
Halo Labs
Series C • Philadelphia, United States
HotSpot Therapeutics
Series C • Boston, United States
BioAge
Series C • Richmond, United States
DiscGenics
Series C • Salt Lake City, United States
The Org
helps you hire
great candidates
helps you hire
great candidates
It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.
It’s free to use - try it out today.